0001213900-21-024716.txt : 20210505 0001213900-21-024716.hdr.sgml : 20210505 20210505170031 ACCESSION NUMBER: 0001213900-21-024716 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210503 FILED AS OF DATE: 20210505 DATE AS OF CHANGE: 20210505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CASAMENTO CHARLES J CENTRAL INDEX KEY: 0001117167 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39082 FILM NUMBER: 21894311 MAIL ADDRESS: STREET 1: 99 BELBROOK WAY CITY: ATHERTON STATE: CA ZIP: 94027 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RELMADA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001553643 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 455401931 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 880 3RD AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 646 876 3459 MAIL ADDRESS: STREET 1: 880 3RD AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: CAMP NINE, INC. DATE OF NAME CHANGE: 20120706 4 1 ownership.xml X0306 4 2021-05-03 0 0001553643 RELMADA THERAPEUTICS, INC. RLMD 0001117167 CASAMENTO CHARLES J C/O RELMADA THERAPEUTICS, INC. 880 THIRD AVENUE, 12TH FLOOR NEW YORK NY 10022 1 0 0 0 Common Stock 2021-05-03 4 S 0 3000 38.2157 D 9950 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020. The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range. Sales prices range from $37.94 to $38.94 per share, inclusive. /s/ Charles J. Casamento 2021-05-05